Abstract:MicroRNAs (miRNAs/ miRs) are short, noncoding RNAs, usually consisting of 18 to 24 nucleotides, that control gene expression after the process of transcription and have crucial roles in several clinical processes. This article seeks to provide an in-depth review and evaluation of the many activities of miR-128, accentuating its potential as a versatile biomarker and target for therapy; The circulating miR-128 has garnered interest because of its substantial influence on gene regulation and its simplicity in extraction. Several miRNAs, such as miR-128, have been extracted from circulating blood cells, cerebrospinal fluid, and plasma/serum. The miR-128 molecule can specifically target a diverse range of genes, enabling it to have intricate physiological impacts by concurrently regulating many interrelated pathways. It has a vital function in several biological processes, such as modulating the immune system, regulating brain plasticity, organizing the cytoskeleton, and inducing neuronal death. In addition, miR-128 modulates genes associated with cell proliferation, the cell cycle, apoptosis, plasma LDL levels, and gene expression regulation in cardiac development. The dysregulation of miR-128 expression and activity is associated with the development of immunological responses, changes in neural plasticity, programmed cell death, cholesterol metabolism, and heightened vulnerability to autoimmune illnesses, neuroimmune disorders, cancer, and cardiac problems; The paper highlights the importance of studying the consequences of miR-128 dysregulation in these specific locations. By examining the implications of miRNA-128 dysregulation in these areas, the article underscores its significance in diagnosis and treatment, providing a foundation for research and clinical applications.

microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application

Emerging role of microRNAs in lipid metabolism

Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention

Abstract 24: MicroRNA-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia

MicroRNA-Based Diagnosis and Therapy

Roles of MicroRNAs in Glucose and Lipid Metabolism in the Heart

Abstract 225: Regulation Of Plasma Lipoproteins And Atherosclerosis By Microrna-541-3p And Transcription Factors Znf101 And Casz1

Exploring the versatility of miRNA-128: a comprehensive review on its role as a biomarker and therapeutic target in clinical pathways

The Role of miRNAs in Metabolic Diseases

Microrna-34a: Role In Cancer And Cardiovascular Disease

miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

A New Insight into the Roles of MiRNAs in Metabolic Syndrome

LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases

The Clinical Potential of Circulating Micrornas in Obesity

miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches

microRNAs in cardiovascular disease – clinical application

Application of microRNAs in diagnosis and treatment of cardiovascular disease

MicroRNAs and the heart: small things do matter

Progress in circulating microRNA studies

Regulatory Roles of MicroRNAs in Diabetes